Skip to Main Content

Paper Details

Dual blockade of BRD4 and ATR/WEE1 pathways exploits <i>ARID1A</i> loss in clear cell ovarian cancer.
Res Sq
1
2023
Author NameAffiliation
Katherine L NathansonDivision of Oncological Sciences Knight Cancer Institute, Oregon Health and Science University
Victor E VelculescuThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Ronny DrapkinPenn Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania
Ronny DrapkinHospital of the University of Pennsylvania
Ronny DrapkinPenn Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania
Ronny DrapkinHospital of the University of Pennsylvania
  • 1 - 6

Datasets